Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Radiopharmaceutical market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Radiopharmaceutical market. Detailed analysis of key players, along with key growth strategies adopted by Radiopharmaceutical industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Jubilant Pharma
SIEMENS
GE Healthcare
Navidea
Triad Isotopes
Eli Lilly
Bracco Imaging
Mallinckrodt
Lantheus
Bayer
Nordion
IBA Group
By Type:
Diagnostic Radioisotopes
Therapeutic Radioisotopes
By End-User:
Oncology
Cardiology
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Radiopharmaceutical Market
-
1.3 Market Segment by Type
-
1.3.1 China Radiopharmaceutical Market Size and Growth Rate of Diagnostic Radioisotopes from 2016 to 2027
-
1.3.2 China Radiopharmaceutical Market Size and Growth Rate of Therapeutic Radioisotopes from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Radiopharmaceutical Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.2 China Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2016 to 2027
-
1.4.3 China Radiopharmaceutical Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Radiopharmaceutical Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Radiopharmaceutical by Major Types
-
3.4.1 Market Size and Growth Rate of Diagnostic Radioisotopes
-
3.4.2 Market Size and Growth Rate of Therapeutic Radioisotopes
4 Segmentation of Radiopharmaceutical Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Radiopharmaceutical by Major End-Users
-
4.4.1 Market Size and Growth Rate of Radiopharmaceutical in Oncology
-
4.4.2 Market Size and Growth Rate of Radiopharmaceutical in Cardiology
-
4.4.3 Market Size and Growth Rate of Radiopharmaceutical in Other
5 Market Analysis by Regions
-
5.1 China Radiopharmaceutical Production Analysis by Regions
-
5.2 China Radiopharmaceutical Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Radiopharmaceutical Landscape Analysis
-
6.1 North China Radiopharmaceutical Landscape Analysis by Major Types
-
6.2 North China Radiopharmaceutical Landscape Analysis by Major End-Users
7 Central China Radiopharmaceutical Landscape Analysis
-
7.1 Central China Radiopharmaceutical Landscape Analysis by Major Types
-
7.2 Central China Radiopharmaceutical Landscape Analysis by Major End-Users
8 South China Radiopharmaceutical Landscape Analysis
-
8.1 South China Radiopharmaceutical Landscape Analysis by Major Types
-
8.2 South China Radiopharmaceutical Landscape Analysis by Major End-Users
9 East China Radiopharmaceutical Landscape Analysis
-
9.1 East China Radiopharmaceutical Landscape Analysis by Major Types
-
9.2 East China Radiopharmaceutical Landscape Analysis by Major End-Users
10 Northeast China Radiopharmaceutical Landscape Analysis
-
10.1 Northeast China Radiopharmaceutical Landscape Analysis by Major Types
-
10.2 Northeast China Radiopharmaceutical Landscape Analysis by Major End-Users
11 Southwest China Radiopharmaceutical Landscape Analysis
-
11.1 Southwest China Radiopharmaceutical Landscape Analysis by Major Types
-
11.2 Southwest China Radiopharmaceutical Landscape Analysis by Major End-Users
12 Northwest China Radiopharmaceutical Landscape Analysis
-
12.1 Northwest China Radiopharmaceutical Landscape Analysis by Major Types
-
12.2 Northwest China Radiopharmaceutical Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Jubilant Pharma
-
13.1.1 Jubilant Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 SIEMENS
-
13.2.1 SIEMENS Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 GE Healthcare
-
13.3.1 GE Healthcare Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Navidea
-
13.4.1 Navidea Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Triad Isotopes
-
13.5.1 Triad Isotopes Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Eli Lilly
-
13.6.1 Eli Lilly Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bracco Imaging
-
13.7.1 Bracco Imaging Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Mallinckrodt
-
13.8.1 Mallinckrodt Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Lantheus
-
13.9.1 Lantheus Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Bayer
-
13.10.1 Bayer Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Nordion
-
13.11.1 Nordion Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 IBA Group
-
13.12.1 IBA Group Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Radiopharmaceutical Market Size and Growth Rate of Diagnostic Radioisotopes from 2016 to 2027
-
Figure China Radiopharmaceutical Market Size and Growth Rate of Therapeutic Radioisotopes from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Radiopharmaceutical Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2016 to 2027
-
Figure China Radiopharmaceutical Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Radiopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Radiopharmaceutical Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Radiopharmaceutical
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Radiopharmaceutical by Different Types from 2016 to 2027
-
Table Consumption Share of Radiopharmaceutical by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Diagnostic Radioisotopes
-
Figure Market Size and Growth Rate of Therapeutic Radioisotopes
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Radiopharmaceutical by Different End-Users from 2016 to 2027
-
Table Consumption Share of Radiopharmaceutical by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Cardiology
-
Figure Market Size and Growth Rate of Other
-
Table China Radiopharmaceutical Production by Regions
-
Table China Radiopharmaceutical Production Share by Regions
-
Figure China Radiopharmaceutical Production Share by Regions in 2016
-
Figure China Radiopharmaceutical Production Share by Regions in 2021
-
Figure China Radiopharmaceutical Production Share by Regions in 2027
-
Table China Radiopharmaceutical Consumption by Regions
-
Table China Radiopharmaceutical Consumption Share by Regions
-
Figure China Radiopharmaceutical Consumption Share by Regions in 2016
-
Figure China Radiopharmaceutical Consumption Share by Regions in 2021
-
Figure China Radiopharmaceutical Consumption Share by Regions in 2027
-
Table North China Radiopharmaceutical Consumption by Types from 2016 to 2027
-
Table North China Radiopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure North China Radiopharmaceutical Consumption Share by Types in 2016
-
Figure North China Radiopharmaceutical Consumption Share by Types in 2021
-
Figure North China Radiopharmaceutical Consumption Share by Types in 2027
-
Table North China Radiopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table North China Radiopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure North China Radiopharmaceutical Consumption Share by End-Users in 2016
-
Figure North China Radiopharmaceutical Consumption Share by End-Users in 2021
-
Figure North China Radiopharmaceutical Consumption Share by End-Users in 2027
-
Table Central China Radiopharmaceutical Consumption by Types from 2016 to 2027
-
Table Central China Radiopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure Central China Radiopharmaceutical Consumption Share by Types in 2016
-
Figure Central China Radiopharmaceutical Consumption Share by Types in 2021
-
Figure Central China Radiopharmaceutical Consumption Share by Types in 2027
-
Table Central China Radiopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table Central China Radiopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Radiopharmaceutical Consumption Share by End-Users in 2016
-
Figure Central China Radiopharmaceutical Consumption Share by End-Users in 2021
-
Figure Central China Radiopharmaceutical Consumption Share by End-Users in 2027
-
Table South China Radiopharmaceutical Consumption by Types from 2016 to 2027
-
Table South China Radiopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure South China Radiopharmaceutical Consumption Share by Types in 2016
-
Figure South China Radiopharmaceutical Consumption Share by Types in 2021
-
Figure South China Radiopharmaceutical Consumption Share by Types in 2027
-
Table South China Radiopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table South China Radiopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure South China Radiopharmaceutical Consumption Share by End-Users in 2016
-
Figure South China Radiopharmaceutical Consumption Share by End-Users in 2021
-
Figure South China Radiopharmaceutical Consumption Share by End-Users in 2027
-
Table East China Radiopharmaceutical Consumption by Types from 2016 to 2027
-
Table East China Radiopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure East China Radiopharmaceutical Consumption Share by Types in 2016
-
Figure East China Radiopharmaceutical Consumption Share by Types in 2021
-
Figure East China Radiopharmaceutical Consumption Share by Types in 2027
-
Table East China Radiopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table East China Radiopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure East China Radiopharmaceutical Consumption Share by End-Users in 2016
-
Figure East China Radiopharmaceutical Consumption Share by End-Users in 2021
-
Figure East China Radiopharmaceutical Consumption Share by End-Users in 2027
-
Table Northeast China Radiopharmaceutical Consumption by Types from 2016 to 2027
-
Table Northeast China Radiopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Radiopharmaceutical Consumption Share by Types in 2016
-
Figure Northeast China Radiopharmaceutical Consumption Share by Types in 2021
-
Figure Northeast China Radiopharmaceutical Consumption Share by Types in 2027
-
Table Northeast China Radiopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table Northeast China Radiopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Radiopharmaceutical Consumption Share by End-Users in 2016
-
Figure Northeast China Radiopharmaceutical Consumption Share by End-Users in 2021
-
Figure Northeast China Radiopharmaceutical Consumption Share by End-Users in 2027
-
Table Southwest China Radiopharmaceutical Consumption by Types from 2016 to 2027
-
Table Southwest China Radiopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Radiopharmaceutical Consumption Share by Types in 2016
-
Figure Southwest China Radiopharmaceutical Consumption Share by Types in 2021
-
Figure Southwest China Radiopharmaceutical Consumption Share by Types in 2027
-
Table Southwest China Radiopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table Southwest China Radiopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Radiopharmaceutical Consumption Share by End-Users in 2016
-
Figure Southwest China Radiopharmaceutical Consumption Share by End-Users in 2021
-
Figure Southwest China Radiopharmaceutical Consumption Share by End-Users in 2027
-
Table Northwest China Radiopharmaceutical Consumption by Types from 2016 to 2027
-
Table Northwest China Radiopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Radiopharmaceutical Consumption Share by Types in 2016
-
Figure Northwest China Radiopharmaceutical Consumption Share by Types in 2021
-
Figure Northwest China Radiopharmaceutical Consumption Share by Types in 2027
-
Table Northwest China Radiopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table Northwest China Radiopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Radiopharmaceutical Consumption Share by End-Users in 2016
-
Figure Northwest China Radiopharmaceutical Consumption Share by End-Users in 2021
-
Figure Northwest China Radiopharmaceutical Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Jubilant Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma
-
Figure Sales and Growth Rate Analysis of Jubilant Pharma
-
Figure Revenue and Market Share Analysis of Jubilant Pharma
-
Table Product and Service Introduction of Jubilant Pharma
-
Table Company Profile and Development Status of SIEMENS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS
-
Figure Sales and Growth Rate Analysis of SIEMENS
-
Figure Revenue and Market Share Analysis of SIEMENS
-
Table Product and Service Introduction of SIEMENS
-
Table Company Profile and Development Status of GE Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare
-
Figure Sales and Growth Rate Analysis of GE Healthcare
-
Figure Revenue and Market Share Analysis of GE Healthcare
-
Table Product and Service Introduction of GE Healthcare
-
Table Company Profile and Development Status of Navidea
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea
-
Figure Sales and Growth Rate Analysis of Navidea
-
Figure Revenue and Market Share Analysis of Navidea
-
Table Product and Service Introduction of Navidea
-
Table Company Profile and Development Status of Triad Isotopes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes
-
Figure Sales and Growth Rate Analysis of Triad Isotopes
-
Figure Revenue and Market Share Analysis of Triad Isotopes
-
Table Product and Service Introduction of Triad Isotopes
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Bracco Imaging
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging
-
Figure Sales and Growth Rate Analysis of Bracco Imaging
-
Figure Revenue and Market Share Analysis of Bracco Imaging
-
Table Product and Service Introduction of Bracco Imaging
-
Table Company Profile and Development Status of Mallinckrodt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt
-
Figure Sales and Growth Rate Analysis of Mallinckrodt
-
Figure Revenue and Market Share Analysis of Mallinckrodt
-
Table Product and Service Introduction of Mallinckrodt
-
Table Company Profile and Development Status of Lantheus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus
-
Figure Sales and Growth Rate Analysis of Lantheus
-
Figure Revenue and Market Share Analysis of Lantheus
-
Table Product and Service Introduction of Lantheus
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Nordion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion
-
Figure Sales and Growth Rate Analysis of Nordion
-
Figure Revenue and Market Share Analysis of Nordion
-
Table Product and Service Introduction of Nordion
-
Table Company Profile and Development Status of IBA Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group
-
Figure Sales and Growth Rate Analysis of IBA Group
-
Figure Revenue and Market Share Analysis of IBA Group
-
Table Product and Service Introduction of IBA Group
-
